Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX0VNI
|
||||
Drug Name |
4-Benzoimidazol-1-yl-phenol
|
||||
Synonyms |
CHEMBL348242
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C13H10N2O
|
||||
Canonical SMILES |
Oc1ccc(cc1)n2cnc3ccccc23
|
||||
InChI |
InChI=1S/C13H10N2O/c16-11-7-5-10(6-8-11)15-9-14-12-3-1-2-4-13(12)15/h1-9,16H
|
||||
InChIKey |
YPKCOJPZSAGCHD-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Basic fibroblast growth factor receptor 1 | Target Info | [1587926] | ||
Platelet-derived growth factor receptor | Target Info | [1587926] | |||
KEGG Pathway | MAPK signaling pathway | ||||
Ras signaling pathway | |||||
Rap1 signaling pathway | |||||
PI3K-Akt signaling pathway | |||||
Adherens junction | |||||
Signaling pathways regulating pluripotency of stem cells | |||||
Regulation of actin cytoskeleton | |||||
Pathways in cancer | |||||
Proteoglycans in cancer | |||||
Prostate cancer | |||||
Melanoma | |||||
Central carbon metabolism in cancer | |||||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Angiogenesis | ||||
FGF signaling pathway | |||||
Pathway Interaction Database | Glypican 1 network | ||||
Syndecan-4-mediated signaling events | |||||
N-cadherin signaling events | |||||
FGF signaling pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.